Risk factors for medication-related osteonecrosis of the jaws: A systematic review.
about
Serum levels of RANKL and OPG, and the RANKL/OPG ratio in bisphosphonate-related osteonecrosis of the jaw: Are they useful biomarkers for the advanced stages of osteonecrosis?Authors' reply: Medication-related osteonecrosis of the jaw in osteoporotic patients: prevention and management.Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary PreventionClinical characteristics and recurrence-related factors of medication-related osteonecrosis of the jaw
P2860
Risk factors for medication-related osteonecrosis of the jaws: A systematic review.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Risk factors for medication-related osteonecrosis of the jaws: A systematic review.
@en
type
label
Risk factors for medication-related osteonecrosis of the jaws: A systematic review.
@en
prefLabel
Risk factors for medication-related osteonecrosis of the jaws: A systematic review.
@en
P2860
P356
P1433
P1476
Risk factors for medication-related osteonecrosis of the jaws: A systematic review
@en
P2093
S Ivanovski
P2860
P304
P356
10.1111/ODI.12708
P577
2017-08-02T00:00:00Z